Samsung Electronics Ghana today introduced Samsung Health to the Ghanaian market, showcasing how the Galaxy Watch8 and Samsung Health Monitor app deliver clinically approved health monitoring features. These features, including Blood Pressure, ECG, and Sleep Apnea detection, have been validated and approved by the Food and Drugs Authority (FDA) in Ghana, ensuring local credibility and reliability. The launch took place at ACTIV8 Gym in East Legon, in partnership with the Melcom Group, reinforcing Samsung’s commitment to improving access to digital health innovation in Ghana.
Clinically Approved Health Monitoring Features
Beyond clinical features, Samsung Health also offers:
Event at ACTIV8 Gym
Guests at the launch event experienced live demonstrations of Samsung Health features, including real-time BP, ECG, and Sleep Apnea checks. Representatives from Samsung Ghana, alongside executives from Melcom and ACTIV8, shared their commitment to empowering Ghanaians with smarter, accessible health solutions.
Speaking at the event, Musah Al-Hassan (Head of Mobile, Samsung Ghana) said “Samsung Health is not just an app — it is a health ecosystem. With clinically approved features, we are empowering Ghanaians with trusted health insights right at their fingertips.”
A representative from Melcom Group, Rishi Melwani (Director, ACTIV8) added, “As the parent company of ACTIV8, we are proud to collaborate with Samsung to bring innovation into everyday wellness. This partnership reflects our joint commitment to preventive care and healthier communities.”
Samsung will extend the Samsung Health experience nationwide through a strong network of partners, including: Melcom and ACTIV8 Gyms, Addpharma, Decathlon Ghana, Aviation Social Centre and Samsung Retail Stores across Ghana
From Monday, September 1, 2025, the Galaxy Watch8 will also be available nationwide at a special promotional price of 25% off, giving more Ghanaians the opportunity to access clinically approved health technology at an affordable cost.